Insider Trading History of Maccecchini Maria-luisa

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Maccecchini Maria-luisa since 2006. This trader's CIK number is 1315018. At the time of last reporting, Maccecchini Maria-luisa was the President and CEO of Annovis Bio, Inc.. (stock ticker symbol ANVS). Also see all insider trading activities at Annovis Bio, Inc..

Note that in the past Maccecchini Maria-Luisa also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Annovis Bio, Inc. (ANVS) by Maccecchini Maria-luisa

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ANVS 0 $0 0 $0 52,755 $7,385
2022 ANVS 0 $0 0 $0 32,959 $4,614
2021 ANVS 18,000 $496,980 0 $0 0 $0
2020 ANVS 1,600 $9,600 0 $0 0 $0

Yearly summary of insider trading at Calmare Therapeutics Inc (CTT) by Maccecchini Maria-luisa

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 CTT 2,000 $7,980 0 $0 0 $0


Insider trading activities at 2 companies by Maccecchini Maria-luisa:

1. Annovis Bio, Inc. (ANVS)

2. Calmare Therapeutics Inc (CTT)

Table 1. Insider trading of Annovis Bio, Inc. (ANVS) by Maccecchini Maria-luisa

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-02-06 ANVS Option Ex 52,755 .14 7,385
2022-01-14 ANVS Option Ex 32,959 .14 4,614
2021-10-11 ANVS Buy 18,000 27.61 496,980
2020-01-31 ANVS Buy 1,600 6.00 9,600

Table 2. Insider trading of Calmare Therapeutics Inc (CTT) by Maccecchini Maria-luisa

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-01-04 CTT Buy 2,000 3.99 7,980

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maccecchini Maria-luisa (President and CEO of Annovis Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.